Molecule to Market: Inside the outsourcing space
Molecule to Market takes you inside the contract outsourcing space with industry insights and thoughts direct from the brains of the people that make the headlines (just think of your favourite podcast and that’s what we’re doing, but with drug supply chain shortages instead of unsolved crimes and life science leaders instead of sports stars). Talking everything from pharmaceutical contract research, development and manufacturing to clinical trial packaging, logistics and technology – Molecule to Market is a vital shot of infotainment for anyone who wants in on outsourcing.
- Update frequency
- every 6 days
- Average duration
- 45 minutes
- Episodes
- 235
- Years Active
- 2020 - 2025
Foot on the pedal for Predictive Oncology
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Pamela Bush, Chief Business Officer at Predictive Oncology.
Your host, Raman …
One-hour special: The biopharma outsourcer
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Tushar Misra, Chief Manufacturing Officer at Mersana Therapeutics.
Your host, …
From rural roots to global pharma leader
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Mike Martin, Chief Executive Officer at CAI.
Your host, Raman Sehgal, discusse…
Igniting biotech innovation
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Kathy Fernando, Senior Vice President and Global Head of Pfizer Ignite and Pfi…
From CDMO exit to CDMO+
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Tim Scott, President and CEO, AustinPx.
Your host, Raman Sehgal, discusses the…
From MBO to global, family-run CRO
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Graham Wylie, Executive Chairman at the Medical Research Network (MRN).
Your h…
Attracting and retaining the best talent; a roundtable special
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with:
- James Edgar, Chief People Officer at Sygnature Discovery
- Andrew Mears, CEO …
Breathing life into high potential medicines
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Alok Tayi, Founder and CEO at Vibe Bio.
Your host, Raman Sehgal, discusses…
Molecule to Market is on the move...
In this special episode of Molecule to Market, instead of going inside the outsourcing space of the global drug development sector with your host, Raman Sehgal, you'll hear a special announcement abo…
Barbara’s journey into Biopharma
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Barbara Morgan, Global Vice-President of Pharma and Biotechnology at Kerry.
…
The CDMO CEO that doesn’t sugarcoat
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Marcel Velterop, CEO and Member of the Board at Primopus.
Your host, Raman Seh…
Wheeler CDMO Avengers...assemble!
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Jesse McCool, Co-Founder and CEO at Wheeler Bio.
Your host, Raman Sehgal, disc…
The future is bright, the future is CGT
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Lung-I Cheng, Vice President of Cell & Gene Therapy at AmerisourceBergen.
Your…
The biopharma boss on a mission against mental health disorders
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Shawn Singh, Chief Executive Officer and Director at Vistagen Therapeutics.
Yo…
From semiconductors to life sciences
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Wayne Woodard, CEO at Argonaut Manufacturing Services.
Your host, Raman Sehgal…
The CRO scientist turned entrepreneur
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Richard Weaver, Founder and Managing Director at Drug Discovery Solutions.
You…
CDMO poacher turned biotech gamekeeper
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Vishnu Dwadasi, Director of Manufacturing at Ashvattha Therapeutics Inc.
You…
Q123 M&A roundtable
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with:
- Ross Burn, Chief Executive at CatSci
- James Hales, Senior Director at NorthEdg…
Meet the future of bioreactors
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Will Patrick, CEO at Culture Biosciences.
Your host, Raman Sehgal, discusses t…
Meet the lean, keen biotech
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Ian Walters, CEO and Chairman at Portage Biotech.
Your host, Raman Sehgal, di…